ArticleMaterials today. Bio2026

Engineered bacteria reverses tumor cuproptosis resistance via cancer-associated fibroblast reprogramming for enhanced immunotherapy.

Yuhao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.